Search Results - "Conroy, Melissa J"
-
1
Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1
Published in Scientific reports (18-02-2024)“…Oesophagogastric adenocarcinomas (OAC) are poor prognosis, obesity-associated cancers which may benefit from natural killer (NK) cell-based immunotherapies…”
Get full text
Journal Article -
2
Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
Published in Cells (Basel, Switzerland) (10-02-2022)“…Lung cancer is the leading cause of cancer-related deaths worldwide. There are two main subtypes: small cell lung cancer (SCLC), and non-small cell lung cancer…”
Get full text
Journal Article -
3
Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma
Published in Frontiers in immunology (10-07-2019)“…Oesophageal adenocarcinoma (OAC) is an aggressive malignancy with poor prognosis, and incidence is increasing rapidly in the Western world. Mucosal-associated…”
Get full text
Journal Article -
4
Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells
Published in Journal of cancer research and clinical oncology (01-08-2023)“…Aim Visceral obesity is a key risk factor in the development of oesophagogastric junctional adenocarcinoma (OGJ), predominantly via generation of systemic low…”
Get full text
Journal Article -
5
Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8 + T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients
Published in Frontiers in immunology (13-08-2018)“…The omentum is enriched with pro-inflammatory effector memory CD8 T cells in patients with the obesity-associated malignancy, esophagogastric adenocarcinoma…”
Get full text
Journal Article -
6
The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint Inhibition
Published in Frontiers in immunology (27-01-2022)“…Immune checkpoint inhibitors (ICIs) are being investigated for their role as an adjunct in the multimodal treatment of esophageal adenocarcinoma (EAC). The…”
Get full text
Journal Article -
7
Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses
Published in Pharmaceutics (20-01-2023)“…Glioblastoma multiforme (GBM) is the most common adult primary brain malignancy, with dismal survival rates of ~14.6 months. The current standard-of-care…”
Get full text
Journal Article -
8
Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma
Published in Translational oncology (01-06-2022)“…•Immune checkpoints correlate with higher grade tumours and poor treatment response.•First-line chemotherapies stimulate anti-tumour T cell immunity.•Dual…”
Get full text
Journal Article -
9
Natural killer cell therapy: A new frontier for obesity-associated cancer
Published in Cancer letters (01-06-2022)“…Natural killer (NK) cell infiltration of solid tumours is associated with better outcomes, placing augmentation of NK cell abundance in tumours as an…”
Get full text
Journal Article -
10
Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma
Published in Biomedicines (01-04-2024)“…The presence of an immunosuppressive tumour microenvironment in oesophageal adenocarcinoma (OAC) is a major contributor to poor responses. Novel treatment…”
Get full text
Journal Article -
11
The multifactorial effect of obesity on the effectiveness and outcomes of cancer therapies
Published in Nature reviews. Endocrinology (23-09-2024)“…Epidemiology studies have demonstrated a clear association between obesity and the development of several distinct malignancies, with excessive visceral…”
Get full text
Journal Article -
12
Examination and characterisation of the effect of amitriptyline therapy for chronic neuropathic pain on neuropeptide and proteomic constituents of human cerebrospinal fluid
Published in Brain, behavior, & immunity. Health (01-01-2021)“…Amitriptyline is prescribed to reduce the intensity of chronic neuropathic pain. There is a paucity of validated in vivo evidence in humans regarding…”
Get full text
Journal Article -
13
Measuring Immune Cell Movement Toward the Soluble Microenvironment of Human Tissues Using a Boyden Chamber-Based Migration Assay
Published in Methods in molecular biology (Clifton, N.J.) (2023)“…Migration assays are used to measure cell movement toward a variety of chemoattractants in a controlled environment. Here we describe a method for a Boyden…”
Get more information
Journal Article -
14
CX3CL1 Signaling in the Tumor Microenvironment
Published in Advances in experimental medicine and biology (01-01-2020)“…CX3CL1 (Fractalkine) is a multifunctional inflammatory chemokine with a single receptor CX3CR1. The biological effects elicited by CX3CL1 on surrounding cells…”
Get more information
Journal Article -
15
Characterisation of the effects of pulsed radio frequency treatment of the dorsal root ganglion on cerebrospinal fluid cellular and peptide constituents in patients with chronic radicular pain: A randomised, triple-blinded, controlled trial
Published in Journal of neuroimmunology (15-06-2020)“…Chronic radicular neuropathic pain is a major clinical problem with a life time prevalence of more than 50%. Pulsed radiofrequency (PRF) treatment is a…”
Get full text
Journal Article -
16
Examination and characterisation of burst spinal cord stimulation on cerebrospinal fluid cellular and protein constituents in patient responders with chronic neuropathic pain - A Pilot Study
Published in Journal of neuroimmunology (15-07-2020)“…Patients with neuropathic pain have altered proteomic and neuropeptide constituents in cerebrospinal fluid (CSF) compared to controls. Tonic spinal cord…”
Get full text
Journal Article -
17
Chemokine-targeted therapies: An opportunity to remodel immune profiles in gastro-oesophageal tumours
Published in Cancer letters (28-11-2021)“…Immunotherapies are transforming outcomes for many cancer patients and are quickly becoming the fourth pillar of cancer therapy. However, their efficacy of…”
Get full text
Journal Article -
18
An investigation into the modulation of T cell phenotypes by amitriptyline and nortriptyline
Published in European neuropsychopharmacology (01-02-2020)“…Amitriptyline is prescribed for treating the symptoms of neuroinflammatory disorders including neuropathic pain and fibromyalgia. As amitriptyline has evidence…”
Get full text
Journal Article -
19
Fractalkine Elicits Chemotactic, Phenotypic, and Functional Effects on CX3CR1+CD27− NK Cells in Obesity-Associated Cancer
Published in The Journal of immunology (1950) (15-08-2021)“…Esophagogastric adenocarcinomas (EAC) are obesity-associated malignancies underpinned by severe immune dysregulation and inflammation. Our previous work…”
Get full text
Journal Article -
20
A study of the immune infiltrate and patient outcomes in esophageal cancer
Published in Carcinogenesis (New York) (17-04-2021)“…Cancer patient outcomes and selection for novel therapies are heavily influenced by the immune contexture of the tumor microenvironment. Esophageal cancer is…”
Get full text
Journal Article